Luo B - Search Results

1

Polyphyllin VII induces CTC anoikis to inhibit lung cancer metastasis through EGFR pathway regulation.

Que Z, Luo B, Yu P, Qi D, Shangguan W, Wang P, Liu J, Li Y, Li H, Ke R, Wu E, Tian J. Que Z, et al. Among authors: luo b. Int J Biol Sci. 2023 Oct 16;19(16):5204-5217. doi: 10.7150/ijbs.83682. eCollection 2023. Int J Biol Sci. 2023. PMID: 37928267 Free PMC article.

2

Feiji Recipe inhibits the growth of lung cancer by modulating T-cell immunity through indoleamine-2,3-dioxygenase pathway in an orthotopic implantation model.

Luo B, Que ZJ, Zhou ZY, Wang Q, Dong CS, Jiang Y, Hu B, Shi H, Jin Y, Liu JW, Li HG, Wang L, Tian JH. Luo B, et al. J Integr Med. 2018 Jul;16(4):283-289. doi: 10.1016/j.joim.2018.04.008. Epub 2018 Apr 22. J Integr Med. 2018. PMID: 29752140

3

Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo.

Que Z, Luo B, Zhou Z, Dong C, Jiang Y, Wang L, Shi Q, Tian J. Que Z, et al. Among authors: luo b. Cancer Cell Int. 2019 Jan 29;19:21. doi: 10.1186/s12935-019-0735-z. eCollection 2019. Cancer Cell Int. 2019. PMID: 30718976 Free PMC article.

4

Jingfukang induces anti-cancer activity through oxidative stress-mediated DNA damage in circulating human lung cancer cells.

Que Z, Zhou Z, Luo B, Dong C, Jiang Y, Li H, Tian J. Que Z, et al. Among authors: luo b. BMC Complement Altern Med. 2019 Aug 7;19(1):204. doi: 10.1186/s12906-019-2601-x. BMC Complement Altern Med. 2019. PMID: 31391058 Free PMC article.

5

Proteomics analysis of tumor exosomes reveals vital pathways of Jinfukang inhibiting circulating tumor cells metastasis in lung cancer.

Que ZJ, Luo B, Wang CT, Qian FF, Jiang Y, Li Y, Han XH, Li HG, Liu JX, Tian JH. Que ZJ, et al. Among authors: luo b. J Ethnopharmacol. 2020 Jun 28;256:112802. doi: 10.1016/j.jep.2020.112802. Epub 2020 Mar 30. J Ethnopharmacol. 2020. PMID: 32240782 Free article.

6

Jinfukang inhibits lung cancer metastasis by upregulating CX3CL1 to recruit NK cells to kill CTCs.

Que ZJ, Yao JL, Zhou ZY, Yu P, Luo B, Li HG, Liu JX, Xu HX, Tian JH. Que ZJ, et al. Among authors: luo b. J Ethnopharmacol. 2021 Jul 15;275:114175. doi: 10.1016/j.jep.2021.114175. Epub 2021 Apr 30. J Ethnopharmacol. 2021. PMID: 33933571

7

Establishment of a Nomogram-Based Prognostic Model (LASSO-COX Regression) for Predicting Progression-Free Survival of Primary Non-Small Cell Lung Cancer Patients Treated with Adjuvant Chinese Herbal Medicines Therapy: A Retrospective Study of Case Series.

Luo B, Yang M, Han Z, Que Z, Luo T, Tian J. Luo B, et al. Among authors: luo t. Front Oncol. 2022 Jul 8;12:882278. doi: 10.3389/fonc.2022.882278. eCollection 2022. Front Oncol. 2022. PMID: 35875082 Free PMC article.

8

[The TCR repertoire diversity and its application in the prevention and treatment of lung cancer].

Luo B, Chu X, Yu P, Tian J. Luo B, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2022 Oct;38(10):939-943. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2022. PMID: 36163626 Review. Chinese.

9

Combined chemo-immuno-photothermal therapy based on ursolic acid/astragaloside IV-loaded hyaluronic acid-modified polydopamine nanomedicine inhibiting the growth and metastasis of non-small cell lung cancer.

Xu F, Li M, Que Z, Su M, Yao W, Zhang Y, Luo B, Li Y, Zhang Z, Tian J. Xu F, et al. Among authors: luo b. J Mater Chem B. 2023 Apr 12;11(15):3453-3472. doi: 10.1039/d2tb02328h. J Mater Chem B. 2023. PMID: 37009696

10

Jinfukang inhibits lung cancer metastasis by regulating T cell receptors.

Luo B, Wang P, Tian J, Chu X, Lu X, Yang Y, Zhou Y, Li Y, Que Z. Luo B, et al. J Ethnopharmacol. 2024 Jan 10;318(Pt A):116885. doi: 10.1016/j.jep.2023.116885. Epub 2023 Jul 6. J Ethnopharmacol. 2024. PMID: 37422099

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,321 results

Search Page